NCT06038474View on ClinicalTrials.gov

Descartes-08 for Patients With Systemic Lupus Erythematosus

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2026

Conditions
Systemic Lupus Erythematosus (SLE)
Interventions
DRUG

Descartes-08

Autologous T-cells expressing a chimeric antigen receptor directed to BCMA

Trial Locations (1)

92056

RECRUITING

Profound Research LLC, Oceanside

Sponsors
All Listed Sponsors
lead

Cartesian Therapeutics

INDUSTRY